145
Participants
Start Date
October 1, 2022
Primary Completion Date
December 4, 2024
Study Completion Date
December 31, 2025
Rosuvastatin 10 mg tablet.
"The dose of rosuvastatin was derived from literature describing the doses at which the agents' targeted actions are effective and safe. The 10- mg rosuvastatin dose reflects the lowest prescribed therapeutic dose A serum cholesterol level will be drawn from the whole participants and sent to the central laboratories of El-Demerdash hospital at baseline and at week 12.~At each visit, participants will be requested to return all unused investigational products. Adherence to medication will be assessed by a pill count."
Sertraline Pill
Both control and intervention group will receive the sertraline as a standard therapy
RECRUITING
El demerdash hospital, Cairo
Ain Shams University
OTHER